Veritas In Silico Inc. (130A) Press Release
Non-consolidated Financial Results for the Six Months Ended June 30, 2026 [Under Japanese GAAP]
Earlier from Veritas In Silico
- Joint Patent Application Filed for lncRNA-Targeting Drugs
- Personnel Changes in Executive Officer
- TABLE-Veritas In Silico -2025 parent results
- TABLE-Veritas In Silico - 9-MTH parent results